-
Test that can enhance the likelihood of identifying colorectal cancer produced by Mainz Biomed
19 Apr 2024 15:21 GMT
… methods of colorectal cancer screening?
It stands out from traditional colorectal cancer screening … via a web shop, at pharmacies, or through company health programs … the overall treatment burden. Early detection often means that colorectal cancer can be …
-
Scientists Link a Single Type of Bacteria to Colorectal Cancer
19 Apr 2024 13:12 GMT
April 19, 2024,
by Sharon Reynolds
The bacteria Fusbacterium nucleatum typically resides in the mouth. Researchers have found that Fna C2, a subtype of F. nucleatum, may help colorectal cancers develop and grow.
Credit: National Cancer Institute
The human …
-
GenFleet Therapeutics Announces FDA's Clinical Trial Approval for GFH925 (KRAS G12C Inhibitor) Monotherapy in Phase III Registrational Study Treating Metastatic Colorectal Cancer
19 Apr 2024 12:46 GMT
… and Drug Administration (FDA) has granted the clinical trial approval … colorectal cancer (CRC) patients. It is the first phase III trial … intolerant to the last treatment. The primary objective is … first- and second-line treatments are based on combination …
-
Health Canada Approves KEYTRUDA as a first-line treatment for adult patients with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
19 Apr 2024 16:25 GMT
… [CAPOX]). All study medications, except oral capecitabine, … The most common treatment-related adverse events (≥20% … , classical Hodgkin lymphoma, colorectal cancer, endometrial carcinoma, cervical … the impact of pharmaceutical industry regulation and …
-
Rigosertib sodium by Traws Pharma for Epidermolysis Bullosa: Likelihood of Approval
19 Apr 2024 02:08 GMT
… Carcinoma (ESCC), skin squamous cancer, colorectal cancer, cervical squamous cell cancer, penile … anal squamous cell cancer.
Traws Pharma overview
Onconova Therapeutics (Onconova) … molecule drug candidates for the treatment of cancer. The company’s drug …
-
Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials
18 Apr 2024 07:34 GMT
… driver mutations with FDA approved targeted drugs in metastatic solid … the only KRAS targeted treatments FDA approved in cancer. Specifically … cancer cells. Cancer Chemother Pharmacol. 2006;57(2): … trial in patients with stage II/III colorectal cancer who …
-
HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven Therapeutics, Roche
17 Apr 2024 17:00 GMT
… activities, pharmaceutical companies have their potential drug candidates … is an oral medication functioning as a … breast cancer, and colorectal cancer. The FDA has acknowledged zanidatamab … trials, visit @ HER2+ Treatment Drugs HER2+ Overview HER2+ refers …
-
TOPAZ─1 phase III trial shows AstraZeneca's Imfinzi plus chemotherapy doubled OS rate at three years for patients with advanced biliary tract cancer
17 Apr 2024 03:44 GMT
… ), a HER2-directed antibody drug conjugate, is approved in … and is being assessed in colorectal cancer. It also has been … trial, and it was recently approved in the US for the treatment … approaches to help prevent treatment resistance and drive longer …
-
GH-21 by HUYA Bioscience International for Non-Small Cell Lung Cancer: Likelihood of Approval
20 Apr 2024 07:30 GMT
… 18 years of historical drug development data. Attributes of … under development for the treatment of colorectal cancer, head and neck squamous … and solid tumor. The drug candidate is administered through oral … on GlobalData’s Pharmaceutical Intelligence Center.
-
Mabwell Releases Preclinical Study Results of Multiple Innovative Drugs Released at the 2024 AACR Annual Meeting
16 Apr 2024 17:13 GMT
… of three potential novel drug candidates in poster format … cancer, hepatic cancer, and colorectal cancer. IL-11 not only … effects in multiple preclinical pharmacodynamic models, especially when used … for "Significant New Drugs Development", 2 projects …